We are live on
!
Find out more
Russell Investments Group Portfolio holdings
AUM
$114B
1-Year Est. Return
41.71%
This Fund
S&P 500
This Quarter
Est. Return
-1.29%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$72.8B
AUM Growth
+$380M
(+0.52%)
Cap. Flow
+$6.81B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
21.9%
Holding
3,928
New
233
Increased
1,953
Reduced
1,289
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$4.09B |
| 2 |
Apple
AAPL
|
+$167M |
| 3 |
Amazon
AMZN
|
+$158M |
| 4 |
Broadcom
AVGO
|
+$137M |
| 5 |
KKR.PRD
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$246M |
| 2 |
Vistra
VST
|
+$94.2M |
| 3 |
Philip Morris
PM
|
+$70.3M |
| 4 |
Applovin
APP
|
+$61.7M |
| 5 |
Eli Lilly
LLY
|
+$57.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.46% |
| 2 | Financials | 14% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAWN
2601
DELISTED
Day One Biopharmaceuticals
DAWN
| $130K | ﹤0.01% |
16,340
+16,335
| +326,700% | +$176K |
|
|
RNAM
2602
DELISTED
Avidity Biosciences
RNAM
| $129K | ﹤0.01% |
4,378
+2,621
| +149% | +$81.6K |
|
|
DOO
2603
Bombardier Recreational Products
DOO
$4.69B
| $129K | ﹤0.01% |
3,820
+1,641
| +75% | +$72.1K |
|
2604
Codexis
CDXS
$175M
| $126K | ﹤0.01% |
46,935
-5,365
| -10% | -$20.8K |
|
2605
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.9B
| $126K | ﹤0.01% |
501
-20
| -4% | -$5.54K |
|
2606
Arcturus Therapeutics
ARCT
$223M
| $125K | ﹤0.01% |
11,828
+11,799
| +40,686% | +$187K |
|
2607
Woori Financial
WF
$17.1B
| $125K | ﹤0.01% |
3,748
+160
| +4% | +$5.34K |
|
2608
Nu Skin
NUS
$236M
| $125K | ﹤0.01% |
17,226
+5,080
| +42% | +$36.9K |
|
2609
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $123K | ﹤0.01% |
978
+476
| +95% | +$62K |
|
|
AUNA
2610
Auna
AUNA
$385M
| $123K | ﹤0.01% |
17,317
-17,539
| -50% | -$137K |
|
2611
Artisan Partners
APAM
$2.97B
| $123K | ﹤0.01% |
3,144
-26,656
| -89% | -$1.13M |
|
2612
iShares US Insurance ETF
IAK
$538M
| $123K | ﹤0.01% |
889
| – | – |
|
2613
nLIGHT
LASR
$3.06B
| $121K | ﹤0.01% |
15,571
+11,884
| +322% | +$120K |
|
2614
Celsius Holdings
CELH
$7.28B
| $121K | ﹤0.01% |
3,387
-83,899
| -96% | -$2.29M |
|
|
PBT
2615
Permian Basin Royalty Trust
PBT
$1.56B
| $120K | ﹤0.01% |
12,132
| – | – |
|
|
NAGE
2616
Niagen Bioscience
NAGE
$242M
| $120K | ﹤0.01% |
+17,409
| New | +$109K |
|
2617
Strawberry Fields REIT
STRW
$196M
| $120K | ﹤0.01% |
10,026
+8,115
| +425% | +$93.9K |
|
2618
First Trust Value Line Dividend Fund
FVD
$8.4B
| $119K | ﹤0.01% |
2,676
-2,008
| -43% | -$89.2K |
|
2619
Veeco
VECO
$3.26B
| $117K | ﹤0.01% |
5,841
+1,849
| +46% | +$44.3K |
|
|
EB
2620
DELISTED
Eventbrite
EB
| $117K | ﹤0.01% |
55,323
-39,146
| -41% | -$118K |
|
2621
NovoCure
NVCR
$2.05B
| $116K | ﹤0.01% |
6,529
+5,371
| +464% | +$122K |
|
2622
GlobalFoundries
GFS
$28.9B
| $115K | ﹤0.01% |
3,123
-201
| -6% | -$8.13K |
|
2623
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.43B
| $115K | ﹤0.01% |
923
+817
| +771% | +$109K |
|
2624
Wendy's
WEN
$1.65B
| $114K | ﹤0.01% |
7,821
+4,834
| +162% | +$72.7K |
|
|
SARO
2625
StandardAero Inc
SARO
$9.06B
| $114K | ﹤0.01% |
4,270
-3,964
| -48% | -$106K |
|
Similar funds
Russell Investments Group's Q1 2025 Portfolio in Review
As of Q1 2025, Russell Investments Group held 3,928 positions worth $72.8B, up 0.52% from $72.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Russell Investments Group deployed $6.81B of net new capital in Q1 2025, opening 233 new positions and adding to 1,953 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 3,389,000 shares worth $4.07M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Bank of America Series L, an estimated $246M trimmed.
- Russell Investments Group's largest Q1 2025 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 3,389,000 shares worth $4.07M.
- Russell Investments Group added most to Apple in Q1 2025, an estimated $167M increase.
- Russell Investments Group's biggest Q1 2025 reduction was Bank of America Series L, cutting an estimated $246M.
- Russell Investments Group fully exited Arcadium Lithium plc in Q1 2025, selling an estimated $9.31M.
- Russell Investments Group's ten largest holdings make up 22% of its $72.8B portfolio in Q1 2025.
- Russell Investments Group opened 233 new positions and closed 138 in Q1 2025.
- Russell Investments Group's portfolio value rose 0.52% quarter-over-quarter to $72.8B.
Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.